Progenics Pharmaceuticals Inc (NASDAQ:PGNX)

5.50
Delayed Data
As of May 22
 -0.04 / -0.72%
Today’s Change
3.31
Today|||52-Week Range
7.84
-27.25%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2011

2012

2013

2014
Revenue and IncomeNet Revenues76.9M14.0M7.9M44.4M
 
 
 
 
 
Cost of Goods Sold--499.0K624.0K855.0K
 
 
 
 
Depreciation And Amortization2.1M1.3M939.0K545.0K
 
 
 
 
 
 
Operating ExpensesGross Income--12.2M6.3M43.0M
 
 
 
 
General Expenses72.0M47.7M47.0M42.7M
 
 
 
 
 
Other Operating Expenses405.0K0.000.000.00
 
 
Research And Development53.8M33.0M34.1M27.7M
 
 
 
 
 
Total Operating Expenses74.5M49.5M48.6M44.1M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income2.5M-35.5M-40.7M296.0K
 
 
 
 
 
Extraordinary Credit0.000.00--7.3M
 
 
Extraordinary Charge0.000.00-2.3M-4.2M
 
 
 
Other Expenses7.9M0.000.000.00
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income10.4M-35.4M-42.9M3.4M
 
 
 
 
 
Income Taxes0.000.00-362.0K-989.0K
 
 
 
Net Income10.4M-35.4M-42.6M4.4M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS33.4M34.8M55.8M68.2M
 
 
 
 
 
Shares To Calculate EPS Diluted33.5M34.8M55.8M68.2M
 
 
 
 
 
 
Earnings Per ShareEPS$0.31-$1.02-$0.76$0.06
 
 
 
 
 
EPS Diluted$0.31-$1.02-$0.76$0.06
 
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account